It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-011.mrc:294080707:3007
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-011.mrc:294080707:3007?format=raw

LEADER: 03007cam a22003618a 4500
001 5473068
005 20221110043244.0
008 051013t20052005pau b 001 0 eng
010 $a 2005044863
016 7 $a101259837$2DNLM
020 $a0750654287
024 3 $z9780750654289
029 1 $aNLM$b101259837
035 $a(OCoLC)ocm62103227
035 $a(NNC)5473068
035 $a5473068
040 $aDNLM/DLC$cDLC$dNLM$dUCH$dBAKER$dNNC-M$dOrLoB-B
042 $apcc
050 00 $aRC382$b.S34 2005
060 10 $aWL 359$bS299p 2005
082 00 $a616.8/3306$222
100 1 $aSchapira, Anthony H. V.$q(Anthony Henry Vernon)$0http://id.loc.gov/authorities/names/n93804579
245 10 $aPrinciples of treatment in Parkinson's disease /$cAnthony H.V. Schapira, C. Warren Olanow.
260 $aPhiladelphia, PA :$bButterworth-Heinemann/Elsevier,$c[2005], ©2005.
300 $axi, 372 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tThe role of levodopa and catechol-o-methyltransferase inhibitors /$rMelissa J. Nirenberg and Stanley Fahn -- $gCh. 2.$tDrug therapy : dopamine agonists /$rWerner Poewe -- $gCh. 3.$tOther drug therapies for Parkinson's disease /$rMaria Graciela Cersosimo and William C. Koller -- $gCh. 4.$tPathogenesis of motor complications /$rThomas N. Chase -- $gCh. 5.$tClinical features, pathophysiology, and management of motor complications in Parkinson's disease /$rJose A. Obeso, Maria C. Rodriguez-Oroz and Ivana Zamarbide -- $gCh. 6.$tThe medical management of Parkinson's disease /$rAnthony H. V. Schapira and C. Warren Olanow -- $gCh. 7.$tAblative surgery for Parkinson's disease /$rRyan J. Uitti, John D. Putzke and Robert E. Wharen, Jr. -- $gCh. 8.$tDeep brain stimulation for Parkinson's disease /$rA. L. Benabid, J. F. LeBas, S. Grand, P. Krack, S. Chabardes, V. Fraix, B. A. Wallace, C. Ardouin and P. Pollak -- $gCh. 9.$tGene therapy for Parkinson's disease /$rBiplob Dass and Jeffrey H. Kordower -- $gCh. 10.$tSurgical approaches to the treatment of Parkinson's disease /$rC. Warren Olanow and Anthony H. V. Schapira -- $gCh. 11.$tDepression, psychosis, and cognitive dysfunction in Parkinson's disease /$rKaren A. Sawabini, Jorge L. Juncos and Ray L. Watts -- $gCh. 12.$tGastrointestinal, urological, and sleep problems in Parkinson's disease /$rFabrizio Stocchi -- $gCh. 13.$tNeuroprotection in Parkinson's disease /$rHideki Mochizuki and Yoshikuni Mizuno -- $gCh. 14.$tPhysical therapy in Parkinson's disease /$rMara Lugassy and Jean-Michel Gracies -- $gCh. 15.$tNovel therapeutic approaches to the treatment of Parkinson's disease /$rPeter Jenner.
650 0 $aParkinson's disease$xTreatment.
650 12 $aParkinson Disease$xtherapy.$0https://id.nlm.nih.gov/mesh/D010300Q000628
700 1 $aOlanow, C. W.$q(Charles Warren),$d1941-$0http://id.loc.gov/authorities/names/n92801065
852 00 $boff,hsl$hRC382$i.S34 2005